Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Curevac N.V.

Start price
Target price
Perf. (%)
€4.40
09.06.24
€2.00
09.06.25
-30.05%
22.06.24

Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.28
09.06.24
€1.00
09.06.25
18.29%
22.06.24

Higher EBIT margin than peer group
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€1.32
09.06.24
€1.00
09.06.25
14.39%
22.06.24

Scinai Immunotherapeutics Ltd.

Start price
Target price
Perf. (%)
€2.50
09.06.24
€1.00
09.06.25
32.00%
22.06.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.25
09.06.24
€2.00
09.06.25
13.80%
22.06.24

buy
Replimune Group Inc

Start price
Target price
Perf. (%)
€7.15
09.06.24
€10.00
09.06.25
13.99%
22.06.24

buy
Nextcure Inc.

Start price
Target price
Perf. (%)
€1.28
09.06.24
€2.00
09.06.25
17.08%
22.06.24

buy
Geron Corp.

Start price
Target price
Perf. (%)
€4.40
09.06.24
€8.00
09.06.25
-2.27%
22.06.24

buy
In8bio Inc.

Start price
Target price
Perf. (%)
€1.39
09.06.24
€2.00
09.06.25
-41.01%
22.06.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.25
09.06.24
€12.00
09.06.25
13.80%
22.06.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.88
09.06.24
-
09.06.25
-18.76%
21.06.24

buy
Borussia Dortmund

Start price
Target price
Perf. (%)
€3.61
09.06.24
-
09.06.25
-3.19%
22.06.24

Higher EBIT margin than peer group
Top 10 in its market
Fair valuation
Known brand
Savara Inc.

Start price
Target price
Perf. (%)
€3.62
09.06.24
-
09.06.25
1.66%
22.06.24

buy
Genfit S.A.

Start price
Target price
Perf. (%)
€5.02
09.06.24
-
09.06.25
-27.49%
22.06.24

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€3.16
09.06.24
-
09.06.25
-7.59%
22.06.24

Could be very worthwhile Investment >20% year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€3.20
09.06.24
-
09.06.25
-10.57%
22.06.24

buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.91
09.06.24
-
09.06.25
4.93%
22.06.24

Could be worthwhile Investment >10% per year
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.25
09.06.24
-
09.06.25
13.80%
22.06.24

Could be worthwhile Investment >10% per year
buy
Salesforce.com

Start price
Target price
Perf. (%)
€225.75
08.06.24
€230.00
08.06.25
1.40%
22.06.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very Future proof/growth oriented business model
buy
Green Hydrogen Systems A/S

Start price
Target price
Perf. (%)
€1.36
08.06.24
€1.00
08.06.25
-13.92%
06.07.24

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
positive Cash Flow expected
Standard Investments for future growth
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€29.90
08.06.24
€40.00
30.11.25
-25.84%
22.06.24

Could be very worthwhile Investment >20% year
buy
DBS Group Holdings

Start price
Target price
Perf. (%)
€24.50
08.06.24
-
08.06.25
3.18%
02.07.24

buy
Trigano S.A.

Start price
Target price
Perf. (%)
€138.00
08.06.24
-
08.06.25
-19.35%
02.07.24

buy
Grab Holdings Limited

Start price
Target price
Perf. (%)
€3.40
08.06.24
-
08.06.25
-2.53%
02.07.24

buy
NFON AG

Start price
Target price
Perf. (%)
€5.50
08.06.24
-
08.06.25
7.27%
02.07.24